Mirae Asset Global ETFs Holdings’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$270K Sell
87,349
-3,820
-4% -$11.8K ﹤0.01% 2122
2025
Q1
$318K Buy
91,169
+1,772
+2% +$6.19K ﹤0.01% 2085
2024
Q4
$292K Buy
89,397
+8,308
+10% +$27.1K ﹤0.01% 2189
2024
Q3
$312K Buy
81,089
+16,009
+25% +$61.6K ﹤0.01% 2145
2024
Q2
$201K Buy
+65,080
New +$201K ﹤0.01% 2249